Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha’, in India to treat multiple…
Zydus Lifesciences, an innovation-led life-sciences company with an international presence has launched the world’s first…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biosimilar
Lupin receives positive CHMP opinion for biosimilar Ranibizumab
Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
Lupin’s biosimilar Armlupeg gains U.S.FDA approval
The product will be manufactured at Lupin’s biotech facility in Pune, which was inspected by the U.S. FDA prior to approval
Dr. Reddy’s receives positive CHMP opinion from EMA for AVT03
Dr. Reddy’s Laboratories announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use…
Biocon Biologics signs US settlement with Regeneron to Launch Yesafili Biosimilar by 2026
Settlement agreement allows Biocon Biologics to commercialise interchangeable aflibercept biosimilar Yesafili in the US; launch…
Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE
The approval marks Biocon Biologics’ seventh biosimilar clearance in the US, expanding its oncology portfolio in one of the…
Biocon Biologics receives FDA approval for biosimilar YESINTEK
The biosimilar Ustekinumab-kfce is set for commercialisation in the US by February 2025 under a licensing agreement with Janssen
Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income…
Biocon Biologics' study identifies six policy recommendations to improve access to biosimilars in LMICs, addressing healthcare…
USFDA grants approval of Bkemv to Amgen
Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases
USV and Biogenomics launches Insuquick
Insuquick is a “Make in India” product and is available in all metros, and tier I/II cities